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The diameters of both coronary arteries were decreased by ACh in a dose-
dependent manner, whereas IMA showed a dose-dependent dilation with
ACh. These findings indicate that the endothelial function of IMA is well
preserved, because ACh-induced endothelium-derived relaxing factors could
counteract the contraction of vascular smooth muscle cells induced by ACh.
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Estradiol-17,8 (EI has been shown to improve exercise-induced myocardial
ischemia and reverse acetylcholine IACh)-induced coronary constriction in
female patients with coronary artery disease (CAD). To test this latter effect
in men we studied the effect of intracoronary administration of E (2.5 /lg) in
7 male patients with proven CAD (mean age 52 years). All patients under-
went measurements of coronary artery diameter and coronary blood flow
at rest, after control infusion and after infusion of ACh 1.6 and 16 /lg per
min, using quantitative angiography and intracoronary Doppler flowmetry.
Infusions were performed before and 20 minutes after the intracoronary ad-
ministration of E. Coronary artery diameter was similar after either control
or estradiol-17,8 (mean ± SD; 2.9 ± 0.6 vs 2.8 ± 0.5 mm respectively. P =
NS). E had no effect on the ACh-induced coronary constriction (ACh 1.6 J1.g
per min; 2.7 ± 0.3 vs 2.7 ± 0.2 mm, P = NS; ACh 16 J1.g per min; 2.6 ± 0.3
vs 2.6 ± 03 mm, P = NS; post E vs pre E respectively). Likewise, E had no
effect on basal coronary blood flow compared to control (77 ± 11 vs 75 ± 10
mUmin respectively, P = NS). E had no effect on the ACh-induced changes
in coronary blood flow (ACh 1.6 /lg per min; 95 ± 19 vs 90 ± 22 mL/min, P
= NS; ACh 16 /lg per min; 142 ± 27 vs 137 ± 39 mLlmin, P = NS, post E vs
pre E respectively).
Estradiol-17,8 does not appearto attenuate acetylcholine-induced coronary
constriction nor enhance acetylcholine-induced coronary blood flow in male
atherosclerotic coronary arteries in vivo. This is in contrast to the effect of es-
trogen in menopausal females. This suggests that the coronary vasculature
reacts differently to estrogen in males and females.
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Epidemiologic data suggest beneficial effects of dehydroepiandrosterone
(DHEAI and dehydroepiandrosterone-sulfate (DS) in atherosclerosis and
coronary artery disease. Aging is accompanied by a progressive decline in
the secretion of DHEA and DS, paralleling that of growth hormone (GHI in-
sulin like growth factor I (IGF-I) axis. Previous studies reported a significant
increase of IGF-I serum levels after replacement therapy with DHEA in ad-
vancing age men and IGF-I has been shown to have a potent vasodilator
effect in the forearm arterial blood flow in humans and the rat renal afferent
microvasculature; an effect that can be blocked by inhibition of endothelial
derived relaxing factor (EDRFI, nitric oxide (NO). We investigated the effect
of administration of DHEA on plasma levels of cyclic guanidine monophos-
phate (cGMP), the second messenger of NO activity and an indirect assay of
NO release. We included 34 nonobese men, body mass index (BMI) 22-26
kg/m. age 47-74 years, normotensive and non insulin resistant in a double
blind, placebo controlled, randomized study: 18 were treated with DHEA 150
mg daily for 12 days and 16 with placebo. DHEA increased from 3.7 ± 0.2
to 15.0 ± 1.4 J1.mIL (p < 0.001 I in the DHEA group. No changes were ob-
served in the placebo group. cGMP plasma levels increased from 3.22 ±
0.2 to 6.05 ± 0.21 Pmol/ml(p < 0.005) after administration of DHEA. In the
placebo group no significant changes were observed. BMI, fasting insulin,
serum lipids and blood pressure did not change during the study.
The increase of cGMP in the DHEA treated patients presumably occurs
through increased NO production. We suspect that DHEA increases NO via
IGF-I stimulation and this might be one of the mechanisms of the protective
action of DHEA against coronary ischemic disease.
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2.44 ± 063**
237 ± 0.54'*
2.43 ± 050**
ISDN
distal LAD
50% C. 50% 0
12% C. 81% 0.7% E
20% A. 20% B. 30% C. 30% 0
19% C. 69% 0.12% E
proximal LAD
Group 1:
Group 2:
Control ACh
25/l9 50/l9 100/l9
RCA 2.04 ± 049 1.87 ± 040** 1.62 ± 041** -
LCA 2.06 ± 050 1.92 ± 0.50* 1.80 ± 049** 1.69 ± 046**
IMA 2.02 ± 0.53 2.22 ± 0.56** 236 ± 0.57**
Conclusion:( 1) In only 20% of patients 1 year after CT the endothelium
dependent vasodilation is completely preserved. In 40% of the patients 1
year after CT the endothelium shows segmental heterogeneity in response
to ACH [absence of endothelium dependent vasodilation (type A and B) in
the distal segment]. (2) In the long term course after CT more than 80% of
P have defective endothelial function in proximal and distal segments [ab-
sence of endothelium dependent vasodilation (type A and B) in the proximal
and distal segment]. Moreover approximately 10% have defective vascular
smooth muscle function. Functional assessment of endothelial integrity in
P after CT shows time dependent qualitative differences between proXimal
and distal coronary segments.
Terumitsu Tanaka. Masatoshi Fujita. Tetsuro Fudo. Tomoyuki Iwase.
Shun-ichi Tamaki. Ryuji Nohara. Shigetake Sasayama. Takeda Hospital and Kyoto
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Internal mammary arteries (IMA) are widely used for coronary artery bypass
grafting. and being reported to have a much higher long-term patency rate
than that of saphenous veins. Therefore. we hypothesized that the endothe-
lial function of IMA is better preserved compared with that of coronary ar-
teries. To evaluate the endothelial function of IMA, acetylcholine (ACh) was
selectively injected into IMA and both coronary arteries in 7 male and 4 fe-
male patients (mean age; 61 ± 11 (SD) years) with atypical chest pain and
normal coronary arteriograms. Angiography was repeated before and after
the selective injection of various doses of ACh and 1 mg of isosorbide dini-
trate (ISDN). Injection of ACh into coronary arteries provoked neither chest
pain nor ST-segment shifts. The diameter of IMA and both coronary arteries
was measured with a computer-assisted analysis system. Arterial pressures
and heart rates remained unchanged despite the selective injection of ACh
and ISDN. Diameters (mm) were:
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Variations of Segmental Endothelium Dependent and
Endothelium Independent Vasomotor Tone in the
Long Term Follow Up After Cardiac Transplantation
(Qualitative Changes in Endothelial Function)
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To assess segmental vasoconstrictor and dilator responses in patients af-
ter cardiac transplantation (CT) without obvious angiographic disease we in-
fused the endothelium dependent vasodilator acetylcholine (ACH) and the
endothelium independent vasodilator SIN-1 sequentially into the left coro-
nary artery. ACH infusions always preceded SIN-1 infusions. Responses of
156 nonstenotic coronary segments (LAD and CXI were investigated in 26
patients (PI. Group 1: lOP 11.3 ± 3 months after CT. Group 2: 16 P 52 ±
11 months after CT. Five different responses to ACH followed by SIN-1 were
observed: A) dilation followed by no change (fully preserved endothelium
dependent function). B) dilation followed by further dilation. C) no change
followed by dilation. D) constriction followed by dilation (defective endoge-
nous NO-release and intact vascular smooth muscle function). EI constric-
tion followed by constriction (defective endogenous NO-release and defec-
tive vascular smooth muscle function). Results: Different segmental reaction
types in both groups.
*p < 0.05. **p < 0.01 vs. control values by ANOVA
